Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitis ; volume:7 ; number:1 ; day:14 ; month:7 ; year:2023 ; pages:1-14 ; date:12.2023
Journal of patient-reported outcomes ; 7, Heft 1 (14.7.2023), 1-14, 12.2023
- Creator
-
Twiss, James
Whalley, Diane
Doward, Lynda
Balp, Maria-Magdalena
Brass, Clifford A.
Cryer, Donna
Sanyal, Arun
Anstee, Quentin M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s41687-023-00589-5
- URN
-
urn:nbn:de:101:1-2023101810555187440855
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Twiss, James
- Whalley, Diane
- Doward, Lynda
- Balp, Maria-Magdalena
- Brass, Clifford A.
- Cryer, Donna
- Sanyal, Arun
- Anstee, Quentin M.
- SpringerLink (Online service)
Other Objects (12)
Development of a Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis (NASH-CHECK): Results of a Qualitative Study
A new method to induce nonalcoholic steatohepatitis (NASH) in mice
The burden of nonalcoholic steatohepatitis (NASH) in the United States
Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)
Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study
Nichtalkoholische Steatohepatitis (NASH) und alkoholische Steatohepatitis (ASH)
The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
Die nichtalkoholische Steatohepatitis (NASH): Therapieansätze
Analysis of High-mobility Group A proteins in nonalcoholic steatohepatitis (NASH) and liver cancer
The role of Nrf2 and c-Met for the development of non-alcoholic steatohepatitis (NASH)
Development of a Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis (NASH-CHECK): Results of a Qualitative Study
A new method to induce nonalcoholic steatohepatitis (NASH) in mice
The burden of nonalcoholic steatohepatitis (NASH) in the United States
Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)
Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study
Nichtalkoholische Steatohepatitis (NASH) und alkoholische Steatohepatitis (ASH)
The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
Die nichtalkoholische Steatohepatitis (NASH): Therapieansätze
Analysis of High-mobility Group A proteins in nonalcoholic steatohepatitis (NASH) and liver cancer
The role of Nrf2 and c-Met for the development of non-alcoholic steatohepatitis (NASH)
Development of a Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis (NASH-CHECK): Results of a Qualitative Study
A new method to induce nonalcoholic steatohepatitis (NASH) in mice
The burden of nonalcoholic steatohepatitis (NASH) in the United States
Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)
Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study
Nichtalkoholische Steatohepatitis (NASH) und alkoholische Steatohepatitis (ASH)
The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
Die nichtalkoholische Steatohepatitis (NASH): Therapieansätze
Analysis of High-mobility Group A proteins in nonalcoholic steatohepatitis (NASH) and liver cancer